Proteome Sciences Receives Patent Issuance for TMT Technology in US
19 Mayo 2021 - 12:46PM
Noticias Dow Jones
By Adriano Marchese
Proteome Sciences PLC said Wednesday that it has been issued a
U.S. patent covering the company's TMTcalibrator workflow, relating
to methods of analysis.
The protein-biomarker research company said the patent issuance
enables enhanced fluid biomarker discovery and single-cell
proteomics and forms part of the intellectual property exclusively
licensed to Thermo Fisher Scientific Inc. by the company.
"[It] is a key patent covering our TMTcalibrator technology,
which is at the heart of our precision medicine efforts," Chief
Scientific Officer Ian Pike said.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
May 19, 2021 13:31 ET (17:31 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Proteome Sciences (LSE:PRM)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Proteome Sciences (LSE:PRM)
Gráfica de Acción Histórica
De May 2023 a May 2024